Using engineered microvesicles to deliver important molecules into cells
Programmable Microvesicles for Intracellular Macromolecule Delivery
This study is exploring a new way to help deliver important molecules like proteins and DNA directly into cells using special tiny bubbles called gectosomes, which could make treatments for different diseases more effective.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10993629 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to deliver large molecules, such as proteins and nucleic acids, directly into cells. The approach utilizes specially engineered extracellular vesicles, known as gectosomes, which can efficiently transport these macromolecules across the cell membrane and avoid degradation inside the cell. By enhancing the delivery process, this research aims to improve the effectiveness of therapies that rely on these molecules, potentially leading to better treatment options for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research would include patients with diseases that could benefit from improved intracellular delivery of therapeutic agents, such as genetic disorders or certain cancers.
Not a fit: Patients whose conditions do not involve the need for intracellular delivery of macromolecules may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the delivery of therapeutic macromolecules, leading to more effective treatments for patients with conditions that require intracellular intervention.
How similar studies have performed: Other research has shown promise in using engineered extracellular vesicles for drug delivery, indicating that this approach has potential based on previous successes.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Liu, Xuedong — University of Colorado
- Study coordinator: Liu, Xuedong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.